Cost-Utility Analysis of Dimethyl Fumarate as a First Switch Treatment for Relapsing Remitting Multiple Sclerosis in the Brazilian Public Health Care System
Abstract
Authors
L Fahham L Murta V Teich M Machado P Serafini
L Fahham L Murta V Teich M Machado P Serafini
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now